University of Zambia, School of Medicine
Welcome,         Profile    Billing    Logout  
 2 Trials 
17 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
KHOSA, Celso
SMILE-TB, NCT06253715: Shortened Regimen for Drug-susceptible TB in Children

Recruiting
3
860
RoW
Isoniazid, H, Rifampin, R, Pyrazinamide, Z, Ethambutol, E, Rifapentine, P, Priftin, Moxifloxacin, M, Avelox
Johns Hopkins University, United States Agency for International Development (USAID)
Tuberculosis, Tuberculosis, Pulmonary, Tuberculosis, Lymph Node, Mycobacterium Tuberculosis
09/27
09/27
panTB-HM, NCT05686356: A Pan-TB Regimen Targeting Host and Microbe

Recruiting
2/3
352
RoW
Sutezolid, N-acetyl cysteine, NAC, Pretomanid, Bedaquiline, Rifafour
The Aurum Institute NPC, Ludwig-Maximilians - University of Munich, Stichting Katholieke Universiteit, Wits Health Consortium (Pty) Ltd, Instituto Nacional de Saúde, Mozambique, National Institute for Medical Research, Tanzania, University of Stellenbosch, Sequella, Inc., Global Alliance for TB Drug Development
Tuberculosis
09/25
09/25
NCT05807399: PanACEA - STEP2C -01

Recruiting
2
270
RoW
BTZ-043, Rifampicin, Isoniazid, Pyrazinamide, Moxifloxacin
Michael Hoelscher, Radboud University Medical Center, University of California, San Francisco, University College, London
Pulmonary Tuberculosis, Other Specified Pulmonary Tuberculosis
02/25
02/25
TIMPANI, NCT05590455: Tnf Inhibitors to Reduce Mortality in HIV-1 Infected PAtients with Tuberculosis MeNIngitis

Recruiting
2
130
RoW
Adalimumab Injection
ANRS, Emerging Infectious Diseases
Tuberculous Meningitis, HIV I Infection
12/26
06/27
NCT04038632: Impact of an Innovative Childhood TB Diagnostic Approach Decentralized to District Hospital and Primary Health Care Levels on Childhood Tuberculosis Case Detection and Management in High Tuberculosis Incidence Countries (TB-Speed Decentralisation Study)

Recruiting
N/A
26000
RoW
Decentralization of Childhood TB Diagnosis
Institut National de la Santé Et de la Recherche Médicale, France, UNITAID
Tuberculosis in Children
03/22
03/22
ERASE-TB, NCT04781257: Early Risk Assessment in Household Contacts (≥10 Years) of TB Patients by New Diagnostic Tests in 3 African Countries

Active, not recruiting
N/A
2100
RoW
New test candidates
Michael Hoelscher, European and Developing Countries Clinical Trials Partnership (EDCTP)
Tuberculosis
04/24
04/24
NCT04568967: TB-CAPT EXULTANT - HIV

Active, not recruiting
N/A
1172
RoW
Concentrated urine with Xpert Ultra, Stool with Xpert Ultra
Foundation for Innovative New Diagnostics, Switzerland, Ludwig-Maximilians - University of Munich, Instituto Nacional de Saúde, Mozambique, Centro de Investigação em Saúde de Manhiça, National Institute for Medical Research, Tanzania, Ifakara Health Institute, Ospedale San Raffaele, Swiss Tropical & Public Health Institute, African Society for Laboratory Medicine, Heidelberg University, Barcelona Institute for Global Health
Tuberculosis, HIV Coinfection, Diagnoses Disease
12/24
12/24
NCT04568954: TB-CAPT CORE Truenat Trial

Active, not recruiting
N/A
3987
RoW
Truenat TB platform/TB assays
Foundation for Innovative New Diagnostics, Switzerland, Ludwig-Maximilians - University of Munich, National Institute for Medical Research, Tanzania, Centro de Investigação em Saúde de Manhiça, Instituto Nacional de Saúde, Mozambique, Ifakara Health Institute
Tuberculosis, Diagnoses Disease
06/24
12/24
NCT05989802: Rapid Research in Diagnostics Development for TB Network (R2D2 Kids) and Assessing Diagnostics At POC for TB in Children (ADAPT for Kids)

Recruiting
N/A
2100
RoW
Oral swab molecular testing, Automated Cough Sound Analysis, Automated Lung Sound Analysis, Chest X Ray Computer Aided Detection, Artificial Intelligence algorithm
University of California, San Francisco, Instituto Nacional de Saúde, Mozambique, National Referral Hospital, University of Cape Town, Johns Hopkins University, Elizabeth Glaser Pediatric AIDS Foundation, National Institute of Allergy and Infectious Diseases (NIAID), University of California, Irvine
Tuberculosis, Diagnostics, Global Health
09/26
09/26
Archary, Moherndran
ORCHID, NCT04746547: Pharmacokinetics of Twice or Once Daily DTG (50mg) in Children With HIV and TB

Recruiting
4
20
RoW
Dolutegravir 50 MG, Dolutegravir 10 MG
University of KwaZulu, Centre for the AIDS Programme of Research in South Africa
Tuberculosis, Hiv
07/25
07/25
NCT03016533: Dolutegravir Study in HIV-1 Participants Completing IMPAACT Studies P1093 and P2019

Completed
3
101
US, RoW
Dolutegravir film-coated tablets, Dolutegravir film-coated dispersible tablets, ABC/DTG/3TC immediate release tablets, ABC/DTG/3TC film-coated dispersible tablets
ViiV Healthcare
HIV Infections
12/24
12/24
SMILE-TB, NCT06253715: Shortened Regimen for Drug-susceptible TB in Children

Recruiting
3
860
RoW
Isoniazid, H, Rifampin, R, Pyrazinamide, Z, Ethambutol, E, Rifapentine, P, Priftin, Moxifloxacin, M, Avelox
Johns Hopkins University, United States Agency for International Development (USAID)
Tuberculosis, Tuberculosis, Pulmonary, Tuberculosis, Lymph Node, Mycobacterium Tuberculosis
09/27
09/27
LATA, NCT05154747: Long-Acting Treatment in Adolescents

Active, not recruiting
3
476
RoW
Cabotegravir, Rilpivirine Drug Combination, CAB, RPV, TLD
University College, London, European and Developing Countries Clinical Trials Partnership (EDCTP), Janssen-Cilag Ltd., ViiV Healthcare, Department of Clinical Pharmacy, University Medical Centre St Radboud, The Netherlands., London School of Hygiene and Tropical Medicine, MRC/UVRI and LSHTM Uganda Research Unit, Africa Health Research Institute, PENTA Foundation, University of York
Hiv, HIV Infections, HIV-1-infection, Paediatric Human Immunodeficiency Virus Infection
03/25
03/26
D3 (Penta21), NCT04337450: DTG/3TC Fixed Dose Formulations for the Maintenance of Virological Suppression in Children with HIV Infection Aged 2 to <15 Years Old

Recruiting
2/3
370
Europe, RoW
Dolutegravir (DTG) and lamivudine (3TC), SOC
PENTA Foundation, MRC CTU at UCL, AMS-CMU/IRD (PHPT), Chris Hani Baragwanath Academic Hospital, Durban International Clinical Research Site, Hospital Universitario 12 de Octubre, Prapokklao Hospital, Chantaburi, Chiangrai Prachanukroh Hospital, Nakornping Hospital, Khon Kaen Hospital, Kalasin Hospital, Joint Clinical Research Center, MU-JHU CARE, Baylor College of Medicine, Great Ormond Street Hospital for Children NHS Foundation Trust, University Hospital Birmingham NHS Foundation Trust, Department of Clinical Pharmacy, University Medical Centre St Radboud, The Netherlands., Advanced Pathogens Diagnostics Unit, University College London Hospitals, Centre for Health Economics, University of York, Department of Molecular and Clinical Pharmacology, University of Liverpool, Chang Mai Univerity, St Mary's Hospital, London
HIV Infections
09/25
09/25
COMET-PACE, NCT05124210 / 2021-003717-18: Pharmacokinetics, Pharmacodynamics, and Safety of Single-dose Sotrovimab in High-risk Pediatric Participants With Mild to Moderate COVID-19

Terminated
2
8
US
Sotrovimab
GlaxoSmithKline, Vir Biotechnology, Inc.
COVID-19
06/23
06/23
NCT04648280: Safety and Pharmacokinetics Evaluation of Fostemsavir + (OBT) in HIV-1 Infected Children and Adolescents Who Are Failing Their CART and Have Dual- or Triple-class Antiretroviral Resistance

Recruiting
1/2
60
US, RoW
Fostemsavir
PENTA Foundation, ViiV Healthcare, PHPT Foundation, Hospital Universitario 12 de Octubre, Cromsource
HIV Infections with Multi Drug Resistant Virus
06/25
06/28
ATTUNE, NCT06721078: Evaluation of Long-Acting Injectable (LAI) and Teen Clubs in Adolescents ().

Not yet recruiting
N/A
1400
NA
Peer navigation effectiveness
Africa Health Research Institute, National Institutes of Health (NIH), National Institute on Minority Health and Health Disparities (NIMHD)
Hiv
12/28
12/29

Download Options